Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Sep 20, 2016 $23.56 $23.76 $21.65 $22.86 981 200
Sep 19, 2016 $22.50 $23.65 $22.20 $22.89 597 800
Sep 16, 2016 $20.31 $22.76 $20.21 $22.57 698 100
Sep 15, 2016 $20.65 $20.83 $20.03 $20.47 446 900
Sep 14, 2016 $18.93 $21.42 $18.61 $20.54 1 448 300
Sep 13, 2016 $18.90 $19.09 $18.21 $18.47 199 400
Sep 12, 2016 $18.45 $19.33 $18.31 $19.27 273 500
Sep 09, 2016 $19.67 $19.90 $18.52 $18.58 527 100
Sep 08, 2016 $18.83 $20.00 $18.70 $19.89 339 200
Sep 07, 2016 $17.82 $18.92 $17.82 $18.84 435 300
Sep 06, 2016 $17.57 $18.02 $17.42 $17.85 129 300
Sep 02, 2016 $17.41 $17.91 $17.06 $17.45 147 200
Sep 01, 2016 $17.11 $17.36 $16.90 $17.28 217 200
Aug 31, 2016 $18.24 $18.24 $16.90 $16.99 225 100
Aug 30, 2016 $18.30 $18.55 $18.07 $18.23 213 000
Aug 29, 2016 $18.35 $18.59 $18.00 $18.17 121 000
Aug 26, 2016 $18.05 $18.65 $18.00 $18.28 149 700
Aug 25, 2016 $18.50 $19.63 $17.78 $18.05 599 400
Aug 24, 2016 $19.44 $19.92 $18.18 $18.42 255 800
Aug 23, 2016 $19.56 $19.77 $19.14 $19.38 195 800
Aug 22, 2016 $19.72 $19.92 $19.26 $19.48 146 500
Aug 19, 2016 $19.87 $20.15 $19.24 $19.54 363 900
Aug 18, 2016 $19.50 $20.15 $19.33 $20.00 317 400
Aug 17, 2016 $21.65 $21.65 $19.33 $19.52 566 100
Aug 16, 2016 $21.50 $22.28 $21.12 $21.39 452 000
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT